rxstat › Classes › All Other Therapeutic Products
All Other Therapeutic Products: shortage status in Canada
8 of the 18 all other therapeutic products rxstat tracks are currently in shortage in Canada, including 1 designated Tier 3 (most serious) by Health Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Mesna (Uromitexan) Widespread shortage 3 of 3 reported products affected · est. return Aug 31, 2026
Polystyrene Sulfonate (Solystat) Widespread shortage 3 of 6 reported products affected · est. return Oct 9, 2026
Deferasirox Partial shortage 1 of 21 reported products affected
Dexrazoxane (Zinecard) Partial shortage 1 of 3 reported products affected
Hydroxocobalamin (Cyanokit) Partial shortage 1 of 1 reported products affected
Leucovorin Partial shortage 1 of 6 reported products affected · est. return Aug 28, 2026
Methylene Blue Partial shortage 1 of 2 reported products affected
Polystyrene Sulfonate (Resonium Calcium) Partial shortage 1 of 2 reported products affected
Naloxone Shortage anticipated 0 of 8 reported products affected
Alcohol Anhydrous Discontinued 0 of 1 reported products affected
Cobicistat (Tybost) Discontinued 0 of 1 reported products affected
Deferoxamine (Desferal) No current shortage
Digoxin Immune Fab (Digifab) No current shortage
Dimercaprol (Bal In Oil) Discontinued 0 of 1 reported products affected
Lanthanum (Fosrenol) Discontinued 0 of 4 reported products affected
Protamine No current shortage
Sevelamer (Renagel) No current shortage
Sevelamer Carbonate (Renvela) No current shortage
Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.